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Analysis of a Standardized Perioperative Pain Management
Order Set in Highly Opioid-Tolerant Patients
Alex N. Isaacs, PharmD, BCPS,*† Kellie L. Knight, PharmD, BCPS,‡ and Sarah A. Nisly, PharmD, BCPS‡§
Objective: The aim was to assess a standardized order set for periopera-
tive pain management in highly opioid-tolerant patients undergoing elec-
tive orthopedic surgery.
Methods: This retrospective chart review evaluated a pain order set in
highly opioid-tolerant patients undergoing elective total knee or total hip
arthroplasty from January 2010 through August 2012. Based on the date
of the surgery, patients were allocated into preimplementation or postim-
plementation order set groups. The primary outcome assessed whether an
adjustment in daily opioid dosage was required within the first 48 hours
postoperatively. Secondary outcomes included pain scores, length of hospi-
talization, and safety outcomes.
Results: Sixty patients were included in the analysis. An adjustment to
postoperative opioid therapy occurred in 62% of the patients in the preim-
plementation group and in 56% of postimplementation group patients
(P = 0.786). There were no differences in median pain scores 48 hours
postoperatively (P = 0.348). Cumulative toxicity was increased after order
set implementation compared with previous patients (44% versus 5%,
P < 0.005); however, opioid doses held for sedation was the only individual
toxicity to reach statistical significance (P = 0.011).
Conclusions: This study is the first to evaluate a standardized order set
for pain management in highly opioid-tolerant patients undergoing elective
orthopedic surgery. The order set demonstrated similar efficacy to previous
treatment modalities, but opioid-induced sedation was of concern with the
order set. After the initial analysis, the order set was modified to minimize
opioid-induced sedation. Continual safety analysis is warranted for quality
improvement to enhance perioperative pain management in highly opioid-
tolerant patients.
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In 2001, The Joint Commission created analgesic standards tofacilitate adequate assessment, treatment, and patient education
surrounding pain management.1 With the increased use of opioids
within the United States, there is a greater risk of developing tol-
erance as frequent exposure to these medications results in subse-
quent desensitization to their effects, necessitating higher doses.2,3
Opioid tolerance produces many challenges to overcome in the
treatment of acute pain, including balancing pain control with
adverse drug reactions.
In 2010, there were more than 1 million orthopedic surgical
procedures performed in the United States.4 In the perioperative
setting, effective pain management and use of a standardized pain
pathway in orthopedic patients can enhance patient satisfaction
scores, reduce length of hospitalization, minimize health care costs,
and prevent hospital readmissions and clinic visits.3,5–9 However,
achieving pain control may be more challenging in opioid-tolerant
patients.3,5,7 Opioid tolerance has been defined as patients using
60 mg or more of oral morphine equivalents daily for more than
1 week.3,5,10 Opioid-tolerant patients often require higher dosages
to attain adequate pain control, which must be balanced with the
enhanced risk for potential toxicities, including respiratory de-
pression and oversedation.3,5 In a study by Oderda et al,11 opioid-
related adverse drug eventswere 75%more likely to occur in ortho-
pedic surgical patients and 31% more likely in patients receiving
greater than or equal to 10 mg of oral morphine equivalents daily.
Orthopedic surgery patients in this study who experienced opioid-
related adverse events had an increased hospital length of stay by
0.52 days and an increase in health care costs by 7.4%.
Despite the opioid epidemic and escalating number of ortho-
pedic surgeries performed annually in the United States, there
is limited primary literature on perioperative pain management
in highly opioid-tolerant patients, as current recommendations
are derived from anecdotal and expert opinions.3,5,6 Standardizing
order sets are supported by the Institute for Safe Medication Prac-
tices (ISMP) to enhance patient care through improved efficacy
and safety outcomes.12 Although standardized pain management
has proven beneficial in orthopedic surgical settings, there is a
lack of literature on perioperative pain management in highly
opioid-tolerant patients.5–8,10,13–15 With the rising prevalence of
opioid tolerance, the aim of this research was to retrospectively
evaluate the efficacy and safety of a standardized perioperative
pain management order set in highly opioid-tolerant patients
undergoing elective total knee arthroplasty (TKA) or total hip
arthroplasty (THA).
METHODS
This retrospective chart review evaluated a standardized
perioperative pain management order set for orthopedic sur-
gery patients at Indiana University Health Methodist Hospital,
an 800-bed, level 1 trauma center located in Indianapolis, IN. Be-
fore the order set, there was no standardized treatment plan for the
management of acute perioperative pain in orthopedic surgery pa-
tients. There was large variability in prescribing with patients re-
ceiving scheduled and as-needed oral and intravenous opioids
with adjunctive nonopioid medications.
In May 2011, a multidisciplinary team composed of physicians,
nurse practitioners, physician assistants, nurses, pharmacists, and
other health care professionals developed a perioperative pain man-
agement order set to improve postoperative pain scores and enhance
patient satisfaction. The order set was first piloted by 1 orthopedic
surgeon who performs primarily elective TKA or THA. The order
set classifies patients into 1 of 3 different categories based on pre-
scribed daily opioid use before hospital admission (Appendix A,
Supplemental Digital Content 1, http://links.lww.com/JPS/A34).
Within 30 days before the elective procedure, patients underwent
a preoperative clearance visit with an internal medicine physician
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and, as appropriate, were referred to specialists for surgical clear-
ance. In addition, medication histories were obtained at this ap-
pointment. At the time of admission, medication histories were
again verified by nursing or pharmacy personnel. Any scheduled
and as-needed opioid prescriptions used for more than 6 weeks
before surgery were included in the quantification of opioid doses
to determine the classification of opioid tolerance. A previous
internal evaluation illustrated the benefit of the standardized
pain management order set, but very few highly opioid-tolerant
patients were included in this analysis. As per the derived order
set, patients using an average daily dose greater than 90mg of oral
morphine equivalents were categorized as highly opioid tolerant
(opioid tolerance level 3).
Treatment options for highly opioid-tolerant patients are
illustrated in Appendix A (Supplemental Digital Content 1,
http://links.lww.com/JPS/A34). For treatment in the preoperative
setting, highly opioid-tolerant patients could receive an oral
long-acting opioid the morning before surgery. The postoperative
treatment options for highly opioid-tolerant patients included in-
travenous patient-controlled analgesia, scheduled oral long-acting
opioids, scheduled and as-needed short-acting oral medications,
and/or as-needed intravenous opioid therapy for breakthrough pain.
In addition, providers were encouraged to continue patients on any
home pain medications and initiate nonopioid adjuvant therapy, in-
cluding celecoxib, ketorolac, acetaminophen, and/or pregabalin.
The multidisciplinary team developing the order set selected adju-
vant therapies based on the literature within arthroplasty16–18 and
clinical experience with these medications; however, there were
additional nonopioid adjunctive therapies not on the order set,
which were formulary and available at the discretion of prescribers.
All opioid tolerance level 3 patients undergoing TKA or THA
performed by 1 orthopedic surgeon from January 2010 through
August 2012 were screened for study inclusion. Patients were
eligible for inclusion if they were 18 years or older and hospital-
ized for more than 48 hours postoperatively. Patients were ex-
cluded from the analysis if the incorrect opioid tolerance level
was selected based on the preadmission medication history. As
the order set was implemented inMay 2011, patients were catego-
rized into study groups based on whether the surgery occurred
before or after the implementation (Fig. 1).
The primary outcome assessed whether an adjustment in daily
opioid dosage was required from the immediate postoperative or-
ders to 48 hours postoperatively. To determine opioid doses, all
initially prescribed scheduled and as-needed opioids were con-
verted into oral morphine equivalents to establish the immediate
postoperative dose. Daily oral morphine equivalents were calcu-
lated at 48 hours after surgery and compared with the immediate
postoperative dosages to determine if a change in opioid therapy
occurred. If a change occurred, additional analysis evaluated if
this was an escalation or deescalation in opioid therapy.
Secondary outcomes were pain scores and hospital length of
stay. Pain scores were recorded in the electronic medical record
by nurses using a 10-point Likert rating scale with 0 signifying
the absence of pain and 10 representing severe pain. The nursing
staff recorded pain scores at baseline before surgery, after each
opioid administration, and every 2 to 4 hours for the first 24 hours
postoperatively, then every 4 to 6 hours thereafter. Baseline pain
scores were preoperative assessments of pain within 6 hours
before surgery. Median pain scores at baseline and 48 hours
postoperatively were analyzed. The hospital length of stay was
defined as the number of days admitted at the hospital, including
preoperative, operative, and postoperative days. Readmissions
after discharge were not evaluated or included within the hospital
length of stay.
The primary safety outcome was the cumulative occurrence of
respiratory depression, doses held for sedation, and acute kidney
injury in both treatment groups. Respiratory depression was de-
fined as a respiratory rate of less than 8 breaths per minute or
use of the opioid antagonist, naloxone, for the reversal of respira-
tory depression. Sedation was defined as scheduled or patient-
requested opioid doses, which were held owing to increased patient
sedation as noted by a nurse in the electronic medical record. Acute
kidney injury was evaluated to determine the safety of adjunctive
medications used for pain management. Acute kidney injury was
classified using the RIFLE criteria as an increase in serum creati-
nine greater than 2 times the patient's baseline preoperative labora-
tory serum creatinine.19
Categorical data including the primary outcome and safety
data were analyzed using the χ2 test. Nonparametric continu-
ous pain scores for the preimplementation group were compared
with those of the postimplementation group using the Mann-
Whitney U-test. Data were analyzed using SPSS version 19. For
all statistical analysis, a P value of less than 0.05 was used to
define statistical significance.
RESULTS
There were 498 patients screened for inclusion (Fig. 2). Sixty-
four patients were classified as highly opioid tolerant but 3 were
excluded because they were inappropriately classified, and 1 was
hospitalized for less than 48 hours postoperatively. A total of
60 patients met inclusion for review, 21 patients in the preimple-
mentation group and 39 patients in the postimplementation group.
Baseline characteristics were similar between groups with no sta-
tistical differences noted (Table 1). Preadmission daily opioid use
was similar between the 2 groups, with median daily dose 180 mg
for the preimplementation group and 195 mg for the postimple-
mentation group.
Adjustments to either as-needed or scheduled opioid therapy in
the 48-hour postoperative period occurred in 13 patients (62%) in
the preimplementation group and in 22 patients (56%) in the post-
implementation group (P = 0.786) (Fig. 3). Patients in the preim-
plementation group had a trend toward escalation of total opioid
therapy available (52% versus 28%, P = 0.065), whereas patients
in the postimplementation group trended toward a deescalation of
opioid therapy available (28% versus 9%, P = 0.114); however,
neither individual adjustment reached statistical significance.
Secondary outcomes are highlighted in Table 2. Median pain
scores 48 hours after surgery were 6 of 10 for each group (P =
0.348). Moreover, hospital lengths of stay were identical in
both groups at 3.33 days (P = 0.926). There was increased cumu-
lative toxicity in the postimplementation group (44% versus 5%,
P < 0.005). However, the only individual toxicity to reach statisti-
cal significance was doses held for sedation (P < 0.011).
DISCUSSSION
With the enhanced use of opioids in the United States, studies
are necessary to evaluate the safety and efficacy of perioperative
FIGURE 1. Study timeline.
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pain management in opioid-tolerant patients. However, there is a
void of literature supporting perioperative pain management in this
patient population. While not assessing opioid tolerance preopera-
tively, there is literature supporting the benefits of standardized
postoperative pain management within orthopedic surgery.6,13,14
A standardized perioperative pain management order set in pa-
tients undergoing a THA illustrated a significant decrease in pain
scores for the first 4 days postoperatively. Although beneficial,
toxicity associated with this treatment strategy was not reported.13
In another study, a standardized multimodal analgesic approach in
TKA patients resulted in significantly lower pain scores and re-
duced opioid consumption in the first 48 hours postoperatively.
Although there were few differences in toxicities between the
groups, nausea and vomiting occurred twice as frequently in the
patients being treated with the standardized pain regimen.14 Lastly,
a study evaluated perioperative outcomes in patients undergoing
FIGURE 2. Patient extraction for study inclusion. MEU, morphine equivalent units; OTL, opioid tolerance level.
TABLE 1. Baseline Characteristics
Characteristic Preimplementation Group (n = 21) Postimplementation Group (n = 39)
Age, mean (SD), y 55 (14.4) 49 (12.5)
Male, n (%) 8 (38) 17 (44)
Height, mean (SD), cm 170 (9.1) 163 (16.6)
Weight, mean (SD), kg 92 (30.1) 89 (28.9)
Serum creatinine, median (IQR), mg/dL 0.80 (0.66–1.26) 0.82 (0.69–1.02)
Preadmission daily opioid dose, mg of oral MEU
Median (IQR) 180 (127–435) 195 (120–270)
Mean (SD) 344 (337) 266 (242)
Type of orthopedic surgery, n (%)
THA 13 (62) 21 (54)
TKA, n (%) 8 (38) 18 (46)
Baseline preoperative pain score, median (IQR) 3 (0–8) 6 (0–9)
IQR, interquartile range; MEU, morphine equivalent units.
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TKA before and after implementation of a clinical pain pathway.
The clinical pain pathway reduced pain scores and opioid con-
sumption in the first 48 hours postoperatively. In addition, there
was a significant reduction in hospital length of stay and total direct
hospital costs after implementation of this treatment algorithm.6
These studies exemplify the potential benefits of a standardized
perioperative pain management in orthopedic surgery patients.6,13,14
Unfortunately, these studies do not distinguish between opioid
use or opioid tolerance before surgery.
The current study is the first to evaluate a standardized treat-
ment approach for opioid-tolerant patients in the perioperative or-
thopedic setting. The treatment modality resulted in similar pain
scores and opioid therapy manipulations between treatment groups.
Although there is some concern for increased toxicity in the post-
implementation group, the definition of opioid-related adverse
effects in this study contributed to the increased incidence of ad-
verse effects compared with the previous literature. In the Oderda
retrospective study of 40,368 surgical patients, opioid-related
adverse drug effects occurred in 741 patients (1.8%).10 A sep-
arate analysis of administrative claims data demonstrated opioid-
related adverse drug events occurring in 13.6% of surgical
patients.20 Because these studies did not assess sedation, the cur-
rent study had more frequent adverse effects because of the inclu-
sion of opioid doses held for sedation as an opioid-related adverse
effect. Excluding sedation, the other adverse effects were similar
between treatment groups in the current study.
Standardized treatment algorithms have been adopted in the
inpatient setting for a variety of patient populations to minimize
interprescriber variability resulting in enhanced patient safety
and outcomes. These order sets are encouraged by the ISMP to
reduce variability, enhance workflow, encourage evidenced-
based care, and reducemedication errors.12 Utility of standardized
order sets has demonstrated enhanced efficacy and safety when
used within the hospital setting for the management of pneumo-
nia,21 sepsis,22,23 cirrhosis,24 venous thromboembolism prophy-
laxis,25 and patients on warfarin therapy.26
Developing safe and effective standardized order sets is a
priority of The Joint Commission.27 Order sets should be de-
signed to limit selections to appropriate therapeutic options based
on patient-specific characteristics. This systematic approach al-
lows providers to receive specific direction, while simultaneously
eliminating duplicate choices.27,28 If multiple options within a
drug class are prescribed, The Joint Commission standards high-
light the importance of having clear instructions for use of each
duplicate agent.27 Explicit instructions enable nursing and other
health care providers to deliver safe and effective care as directed
by the prescriber. Specifically for opioids, The Joint Commission
highlights the importance of safe and judicious prescribing with
clear instructions for other health care providers administering
medications to help minimize opioid-related adverse effects.28
In relation to the current study, the order set was developed with
as-needed opioid orders having specific instructions for nursing
personnel of when to administer the medications to patients. Clear
instructions incorporating the patient pain score and cognitive
function help ensure patient safety while assisting in pain con-
trol. Irrespective of benefit, standardized order sets require a
multidisciplinary team to carefully and thoroughly construct its
components. In addition, after implementation of an order set,
routine analysis and quality improvement are necessary to ensure
optimal patient outcomes.
FIGURE 3. Primary outcome.
TABLE 2. Secondary Outcomes
Secondary Outcome Preimplementation Group (n = 21) Postimplementation Group (n = 39) P
Pain score, median (IQR) 6 (5–8) 6 (4–8) 0.568
Hospital length of stay, median (IQR), d 3.33 (3.2–4.2) 3.33 (3.0–4.3) 0.926
Cumulative toxicity, n (%) 1 (5) 17 (44) 0.005
Respiratory depression 1 (5) 6 (15) 0.404
Naloxone administration 0 (0) 4 (10) 0.287
Opioid doses held for sedation, n (%) 0 (0) 10 (26) 0.011
Acute kidney injury, n (%) 0 (0) 1 (3) 1.00
IQR, interquartile range.
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After this initial analysis, opportunities for improvement were
identified and implemented to enhance the clinical utility of the
standardized perioperative pain management order set. The cur-
rent study that revealed more opioid doses were held for sedation
after the implementation of the order set. Therefore, the order set
was modified to eliminate the long-acting and short-acting dupli-
cations in scheduled opioid therapy (Appendix B, Supplemental
Digital Content 2, http://links.lww.com/JPS/A35). In addition, to
minimize the sedative effects of opioid therapy associated with this
treatment approach, multidisciplinary education on opioid induced se-
dation was performed. Since the inclusion period for this analysis, the
use of the order set has been expanded and is now available for use
within the entire hospital including surgical and medical services. In
addition, computerized physician order entry has been implemented,
and the order set has been computerized. Lastly, there are efforts under-
way to implement use of the updated order set within the entire health
care system. Continual quality improvement through evaluation
and enhancement of the order set will be necessary to optimize
pain management in opioid-tolerant patients.
This study does have limitations. The retrospective nature of
the study limits data collection, patient randomization, and
follow-up assessment. Because of the study design, the patients
managed with the order set had to be compared with historical
controls, which in itself has inherent limitations. The small sample
size makes it difficult to extract to all opioid-tolerant orthopedic
patients. Although limiting the analysis to 1 surgeon is beneficial
for reduction in prescribing variability, this may have prevented
adjustment in opioid therapy compared with studies with multiple
providers. Moreover, evaluating each patient's opioid tolerance
was heavily dependent on accurate medication histories per-
formed at the preoperative visit. Finally, patients within the highly
opioid tolerance group had large variability in home opioid use,
making it difficult to control for variability between groups.
Despite the limitations, this remains the first study evaluating
the impact of the standardization of perioperative pain manage-
ment in highly opioid-tolerant orthopedic surgery patients.
CONCLUSIONS
Standardized order sets are an organized approach to safe and
effective perioperative pain management as supported by The
Joint Commission and ISMP. This study is the first to evaluate
a standardized order set for pain management in highly opioid-
tolerant patients undergoing elective orthopedic surgery. The order
set demonstrated similar efficacy to previous treatment modal-
ities, but opioid-induced sedation was of concern after imple-
mentation of the standardized order set. After the initial analysis,
a modification to the order set was implemented to minimize
the risk of opioid-induced sedation. As with any new order
set, continual safety analysis is warranted for quality improve-
ment to enhance perioperative pain management in highly opioid-
tolerant patients.
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